Posted inBiogen Inc Centers for Medicare and Medicaid Services Decisions and Verdicts Drugs (Pharmaceuticals) Eisai Co Ltd Food and Drug Administration Medicare Memory United States
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.